Spacelabs Medical
This article was originally published in The Gray Sheet
Executive Summary
Successor for outgoing Chairman, President and CEO Carl Lombardi is being sought by the firm's strategic planning committee; the exec plans to retire in May 2002 after 35 years with the company. The Redmond, Washington patient monitor maker also notes that it has retained investment banking firm Gerard Klauer Mattison to "explore strategic alternatives." Defibrillator firm Cardiac Science dropped a $15-per-share bid for the company in January citing a lack of interest from Spacelabs' board and management. Spacelabs stock closed at $12.39 on the Dec. 13 announcement, up 8.7%...